Adam M Veness
CIK 1778623 · SVP, General Counsel and Sec. · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$2.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | SVP, General Counsel and Sec. | — | $82.07 | — | $0 | 4 | 2026-02-04 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | General Counsel | — | $3.02 | — | $0 | 2 | 2023-02-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | SVP, General Counsel and Sec. | 0 | $178.75 | $0 | -$2.40M | 15 | 2021-11-22 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-07 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +1,100 | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.